Trials / Recruiting
RecruitingNCT07320495
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery: The RENEW Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device: Insulin pump TouchCare Nano A8 with the APGO system | Insulin pump Medtrum TouchCare Nano A8 with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. |
Timeline
- Start date
- 2025-06-19
- Primary completion
- 2027-06-19
- Completion
- 2028-06-19
- First posted
- 2026-01-06
- Last updated
- 2026-01-06
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT07320495. Inclusion in this directory is not an endorsement.